Patents by Inventor Falguni PARIKH

Falguni PARIKH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immune stimulatory function and anti-tumor activity of TGF-? primed myeloid derived suppressor cells (MDSC)
    Patent number: 11090333
    Abstract: Embodiments of the disclosure concern methods and compositions related to cancer therapy using myeloid derived suppressor cells (MDSC) as a solo therapy or an adjunct therapy. The MDSCs are prepared by exposing bone marrow cells or blood cells to one or more compositions that induce their differentiation to MDSCs and also to TGF-?1, and in specific embodiments the exposure to TGF-?1 results in the MDSCs having anti-tumor activity and/or immune stimulatory activity.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: August 17, 2021
    Assignee: Baylor College of Medicine
    Inventors: Andrew Sikora, Padmini Jayaraman, Falguni Parikh, Robin Parihar
  • IMMUNE STIMULATORY FUNCTION AND ANTI-TUMOR ACTIVITY OF TGF-ß PRIMED MYELOID DERIVED SUPPRESSOR CELLS (MDSC)
    Publication number: 20190046569
    Abstract: Embodiments of the disclosure concern methods and compositions related to cancer therapy using myeloid derived suppressor cells (MDSC) as a solo therapy or an adjunct therapy. The MDSCs are prepared by exposing bone marrow cells or blood cells to one or more compositions that induce their differentiation to MDSCs and also to TGF-?1, and in specific embodiments the exposure to TGF-?1 results in the MDSCs having anti-tumor activity and/or immune stimulatory activity.
    Type: Application
    Filed: September 14, 2016
    Publication date: February 14, 2019
    Applicant: Baylor College of Medicine
    Inventors: Andrew SIKORA, Padmini JAYARAMAN, Falguni PARIKH, Robin PARAHIR